Learning Objectives:

1. Define certain female specific factors such as preeclampsia and early menopause are “risk-enhancers” that increase CVD risk in women and how to incorporate these factors into shared-decision making with patients about preventive therapies.

2. Articulate the prognostic impact of subclinical atherosclerosis and ischemia with non-obstructive coronary artery disease on women’s future ASCVD risk and opportunities to enhance treatment and prevention

3. Verbalize the  disparities in enrollment of women patients into cardiovascular clinical trials and discuss suggestions for improvement in this area

Session date: 
01/27/2023 - 8:00am to 9:00am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Erin Michos, MD, MHS, FAHA, FACC, FASE, FASPC